Issue |
E3S Web of Conf.
Volume 553, 2024
2024 International Conference on Ecological Protection and Environmental Chemistry (EPEC 2024)
|
|
---|---|---|
Article Number | 05047 | |
Number of page(s) | 5 | |
Section | Medical Treatments and Therapies | |
DOI | https://doi.org/10.1051/e3sconf/202455305047 | |
Published online | 24 July 2024 |
Investigating the effects of SARS-CoV-2 genetic mutations: Transmissibility, clinical severity, diagnostic implications and case study vaccine designs
Biochemical Engineering Department, University Collège London (UCL), United Kingdom
* Corresponding author: zcbelhe@ucl.ac.uk
SARS-CoV-2 comprises a diverse group of viruses responsible for illnesses ranging from the common cold to more serious respiratory diseases. Among coronaviruses, the four primary subgroups of note are Alphacoronavirus, Beta, Gamma, and Delta coronavirus. This paper examines genetic mutations on the transmissibility of variants in comparison to the original strains, emphasizing the potential consequences for pathogenicity and transmissibility. It underscores the significance of identifying genomic variants and their correlation with viral infectivity and COVID-19 severity to facilitate pandemic control and evolution investigation. Furthermore, the review paper explores the intricate relationship between specific mutations and the severity of COVID-19 symptoms, drawing on global data from clinical studies and surveillance to aid healthcare professionals in resource allocation and tailored treatment strategies. The review encompasses analyses of symptom severity, variations in clinical outcomes among different SARS-CoV-2 variants, and innovative approaches such as reverse vaccinology and adapted vaccines targeting Omicron subvariants. These findings collectively contribute to our understanding of the evolving pandemic and offer potential solutions for its mitigation and control.
© The Authors, published by EDP Sciences, 2024
This is an Open Access article distributed under the terms of the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.